The Transition From Chronic Intravenous To Oral Levosimendan Is Safe And Effective In Patients With Pulmonary Hypertension With Heart Failure And Preserved Ejection Fraction
Description
Journal of Cardiac Failure; 04/01/2023(AN S1071916422011526); ISSN: 10719164ScienceDirect
